Sabrina Orsi, a student in the doctoral program in pharmacology and toxicology, won the People’s Choice Award at UB’s eighth annual Three Minute Thesis (3MT) competition.
Peter L. Elkin, MD, professor and chair of biomedical informatics, has been elected to the board of directors of the Association for Clinical and Translational Science (ACTS).
Ninety-five original research projects from aspiring physician-scientists were on display at the 2024 Medical Student Research Forum at the Jacobs School of Medicine and Biomedical Sciences.
The study aims to fill a gap by looking at socioeconomic, racial and ethnic disparities in children’s health and development from birth through the first year.
A number of medical students are gaining valuable clinical research experience studying autonomic disorders under the direction of Svetlana Blitshteyn, MD, a clinical associate professor of neurology at the Jacobs School of Medicine and Biomedical Sciences.
The National Institutes of Health has renewed its funding of eye disease research led by Mark D. Parker, PhD, associate professor of physiology and biophysics.
UB research has identified how a misstep in the genesis of a key component of the kidney causes infantile cystinosis, a rare disease that significantly shortens the lifespan of patients.
UB’s Community Health Equity Research Institute is launching its first-ever pilot funding program to address health equities and adverse social determinants of health. The institute will fund two projects with a maximum budget of $40,000 each.
Children taking psychostimulant drugs prescribed for psychiatric disorders who experience a common childhood fracture take longer to heal than children who don’t take these drugs.
UB researchers found that more than 90 % of those in the telemedicine arm at an opioid treatment program were cured of HCV infection compared to 35.2% of participants referred to an offsite specialist.